Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer
Open Access
- 9 November 2011
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 47 (3) , 266-275
Abstract
Dbait molecules are a new class of DNA repair inhibitors triggering false DNA damage signaling in cancer cells. Dbait has already been shown to be effective in combination with radiotherapy. The aim of this study was to assess the adjuvant impact of Dbait on chemotherapy in vitro and in mouse models of colorectal cancer. We assessed DNA repair efficiency over time, in vitro, in human colon adenocarcinoma HT-29 (wild-type KRAS) and HCT-116 (mutated KRAS) cell lines treated with Dbait in combination with 5-fluorouracil and/or camptothecin. Genetically engineered mice spontaneously developing colorectal tumors in the intestines were selected for the evaluation of treatment efficacy. Dbait delayed the repair of DNA damage induced by chemotherapy in vitro. In APC +/1638N mutant mice, the combination of Dbait and chemotherapy decreased tumor size more effectively than chemotherapy alone (median size: 3.6 vs. 10.85 mm2, P < 0.05). In APC +/1638N/KRAS V12G mutant mice, animals treated with a combination of Dbait and chemotherapy survived significantly longer than animals treated by chemotherapy alone (median survival: 210 vs. 194 days, P < 0.05). A quarter of all the animals treated by chemotherapy alone died as rapidly as untreated animals, whereas the first death was delayed by 29 days by the addition of Dbait. No increase in toxicity due to Dbait was observed in either mouse model. The use of Dbait to inhibit DNA repair may be an effective additional treatment for increasing the efficacy of chemotherapy in colon or rectal cancer, independently of KRAS status.Keywords
This publication has 52 references indexed in Scilit:
- International Preoperative Rectal Cancer Management: Staging, Neoadjuvant Treatment, and Impact of Multidisciplinary TeamsWorld Journal of Surgery, 2010
- Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaksNucleic Acids Research, 2010
- Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage ResponsePLOS ONE, 2009
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in GlioblastomaCancer Research, 2009
- Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-FluorouracilPLOS Biology, 2009
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferencesBritish Journal of Cancer, 2007
- DNA Methyltransferase Inhibitors for Cancer TherapyThe Cancer Journal, 2007
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- APC mutations occur early during colorectal tumorigenesisNature, 1992